Philips' rising market share in MR and the growth of new MR applications are helping drive incremental revenue growth for Intermagnetics General. The company is an exclusive supplier of superconducting magnets to Philips, as well as a developer of MRI
Philips' rising market share in MR and the growth of new MR applications are helping drive incremental revenue growth for Intermagnetics General. The company is an exclusive supplier of superconducting magnets to Philips, as well as a developer of MRI surface coils to multiple OEMs and end users. Second quarter results, released Jan. 8, indicate a 16% rise in earnings for the company (excluding one-time items that netted a substantial gain) to $3.6 million from $3.1 million a year earlier and a net sales increase of 20% to $39 million from $32.4 million. Sales of magnet systems and radio-frequency coils substantially increased due to continued strong demand from MR scanners, offsetting softer results in the company's instrumentation business.
On Jan. 8 the company announced the signing of a definitive agreement to sell the helium-related portion of its subsidiary IGC-APD Cryogenics' business for about $10 million. The sale to Sumitomo Heavy Industries (SHI) of Japan includes all helium-related assets and liabilities. The deal is expected to close in February 2002. The mixed-gas portion of APD Cryogenics' refrigeration systems business, currently conducted at APD's Allentown, PA, facility, will be integrated into IGC-Polycold Systems' new facility in Petaluma, CA. SHI and Intermagnetics also announced a strategic six-year supply agreement under which Intermagnetics will purchase shield coolers used in the production of its MRI magnet systems. Intermagnetics currently purchases all of its shield coolers from either SHI or APD.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.